Skip to main content
Premium Trial:

Request an Annual Quote

Fire Up Those Sequencers

Bertalan Meskó blogs that "the ClinSeq project is really promising." This project is looking into the role that whole-genome sequencing can play in the clinic. The initial phase will enroll about 1,000 people who will give a family and personal medical history and will have about 300 to 400 genes related to atherosclerosis sequenced using a Sanger-based method. At SciFoo he also spoke with George Church, who told him that someone's genome can currently be sequenced for less than $5,000 and that the goal of $1,000 could be possible by the end of the year.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.